Tectonic Therapeutic (TECX) Profit After Tax (2017 - 2026)

Tectonic Therapeutic (TECX) has reported Profit After Tax for 10 consecutive years, with -$25.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Profit After Tax fell 58.69% year-over-year to -$25.2 million; the TTM figure through Mar 2026 stood at -$83.5 million (down 42.34% YoY), while the FY2025 annual figure was -$74.2 million, down 27.93% from the prior year.
• Profit After Tax eased to -$25.2 million in Q1 2026 per TECX's latest filing, from -$19.3 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$7.8 million in Q4 2023 and bottomed at -$29.8 million in Q1 2022.
• Historically, Profit After Tax has averaged -$18.0 million across 5 years, with a median of -$17.7 million in 2024.
• Annual changes were most pronounced in 2023 — Profit After Tax surged 68.66% — and 2024, when it plunged 76.22%.
• Tectonic Therapeutic's Profit After Tax stood at -$25.0 million in 2022, then soared by 68.66% to -$7.8 million in 2023, then plunged by 57.93% to -$12.4 million in 2024, then slumped by 55.56% to -$19.3 million in 2025, then tumbled by 30.95% to -$25.2 million in 2026.
• Business Quant data shows TECX's Profit After Tax at -$25.2 million in Q1 2026, -$19.3 million in Q4 2025, and -$19.0 million in Q3 2025.